Crossmark

Qualitative insights from patient/caregivers, and clinicians on routine use of the EQ-5D-Y-5L in clinical paediatric care—results from a pilot feasibility and acceptability trial

Crossref DOI link: https://doi.org/10.1007/s11136-026-04202-2

Published Online: 2026-03-13

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jones, Renee

Holmes, Kathe

Devlin, Nancy

Dalziel, Kim

Hiscock, Harriet
Funding

Funding for this research was provided by:

University of Melbourne
License Information

Text and Data Mining valid from 2026-03-13

Version of Record valid from 2026-03-13
More Information

Article History

Received: 30 September 2025

Accepted: 13 February 2026

First Online: 13 March 2026

Declarations

:

: Ethics approval was obtained from The Royal Children’s Hospital Human Ethics Committee (HREC/103264/RCHM-2024).

: All participants provided informed consent prior to data collection.

: KD, ND, HH, and RJ have all received previous or current funding from the EuroQol Research Foundation which is the developer and copyright holder of the health-related quality of life instrument included in this study, the EQ-5D-Y-5L. ND is a member of the EuroQol Group. Views expressed in this manuscript are those of the authors and are not necessarily those of the EuroQol Research Foundation.

Document is current

Any future updates will be listed below